Acurx Pharmaceuticals, Inc. leads the list of 10 micro-cap stocks insiders were buying in Q1 2025. The company focuses on developing antibiotics to treat bacterial infections, with promising candidates in clinical trials.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing